Key Record Dates
| ClinicalTrials.gov Identifier: | NCT05026177 |
|---|---|
| Brief Title: | Simufilam 50 mg or 100 mg for Mild-to-Moderate Alzheimer's Disease (REFOCUS-ALZ) |
| First Submitted : | August 9, 2021 |
| First Submitted that Met QC Criteria : | August 25, 2021 |
| First Posted : | August 30, 2021 |
| Last Update Submitted that Met QC Criteria : | January 25, 2024 |
| Last Update Posted : | January 26, 2024 |